Exploring Short-Term Responses to Changes in the Control Strategy for Chlamydia trachomatis
Figure 3
Individual (top) and partner (bottom) positivity after changes to tracing efficiency (left) and annual screening coverage (right) for a baseline prevalence of 8%.
(a) Individual positivity after changing tracing efficiency
(b) Individual positivity after changing screening coverage
(c) Partner positivity after changing tracing efficiency
(d) Partner positivity after changing screening coverage